VividLook MRI

LMI Technology Provides More Accurate Prostate Cancer Diagnosis

LMI Technology provides more accurate prostate cancer diagnosis.

VividLook MRI Provides More Accurate Prostate Cancer Diagnosis

All men are at risk for developing prostate cancer. According to the American Cancer Society (ACS), 1 in 6 men over the age of 40 will develop prostate cancer over their lifetime.

The consensus recommendation is that all men begin to have PSA (prostate-specific antigen) testing beginning at the age of 40. When an elevated PSA is found, a prostate biopsy is usually ordered to confirm the presence of cancer, since early detection is the first step. Since biopsy is often inconclusive, a closer look can mean early diagnosis and a positive outcome.

Lake Medical Imaging has brought the first alternative to surgical biopsy for detection of cancer to Central Florida.

This advanced image analysis technology uses magnetic resonance imaging (MRI) to assist radiologists, urologists, radiation and medical oncologists in the fight against prostate cancer.

Historically, it has been difficult for physicians to image the prostate due to its complex vascularity and its location deep in the pelvic/abdominal cavity.

In addition, we use advanced image analysis software used in the review of prostate MRI images, to give physicians a better view of the prostate gland.

This leading-edge technology provides patients and their physicians more diagnostic assessment which leads to better and more effective treatment options.